Get started
Author

Teresa Cenarro Guerrero

Observed names: T Cenarro Guerrero, T.C. Hernandez Guerrero, Teresa Guerrero, Teresa Guerrero Villegas
Institution: Delfos Hospital
ORCID: 0000-0003-3934-6722
Observed ORCID: 0000-0003-3934-6722
OpenAlex ID: A5005627333
Nontyphoidal Salmonella in Food from Latin America: A Systematic Review
2021 · Teresa Guerrero, Rosa Bayas-Rea, et al. · Foodborne Pathogens and Disease · 37
1025MO First-in-human (FIH) phase I study of RO7122290 (RO), a novel FAP-targeted 4-1BB agonist, administered as single agent and in combination with atezolizumab (ATZ) to patients with advanced solid tumours
2020 · I. Melero, M.F. Sanmamed, et al. · Annals of Oncology · 19
PDF
Salmonella grows massively and aerobically in chicken faecal matter
2020 · Teresa Guerrero, Diana Calderón, et al. · Microbial Biotechnology · 11
PDF
LBA27 First-in-human results of STX-478, a mutant-selective PI3Ka inhibitor, in advanced solid tumor patients
2024 · A.J. Montero, A. Giordano, et al. · Annals of Oncology · 10
PDF
Posibles riesgos para la salud debido al consumo de aspartame
2014 · Teresa Guerrero Villegas, Galo Mora Flores · Enfoque UTE · 6
PDF
Scarlet fever: A not so typical exanthematous pharyngotonsillitis (based on 171 cases)
2015 · César García-Vera, Bárbara de Dios Javierre, et al. · Enfermedades Infecciosas y Microbiología Clínica · 5
625P Initial results from the phase I, first-in-human study of the covalent, PI3Kα inhibitor TOS-358 in patients with solid tumors, expressing PI3Kα mutations or amplifications
2024 · M. Fakih, D. Sohal, et al. · Annals of Oncology · 4
PDF
1073TiP A phase I/IIa first in-human phase I study of BI 1910, a monoclonal antibody agonistic to TNFR2, as a single agent and in combination with pembrolizumab in subjects with advanced solid tumors
2024 · T.C. Hernandez Guerrero, B. Doger de Spéville, et al. · Annals of Oncology · 2
PDF
Complete Genome Sequences of Two Lytic Phages of Salmonella enterica Isolated from Wastewater in Ecuador
2023 · Manuela Parra, Rosa de los Ángeles Bayas-Rea, et al. · Microbiology Resource Announcements · 2
560P Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment
2020 · A.B. Azaro Pedrazzoli, V. Moreno, et al. · Annals of Oncology · 2
Herpes zoster en la consulta de Atención Primaria y su posible relación con varicelas precoces
2009 · J.I. Perales Martínez, Marina Pacheco Miguel, et al. · Hispana · 2
[Tuberculosis: epidemiologic and clinical study of 268 pediatric patients].
1991 · P Domínguez Fenolle, T Cenarro Guerrero, et al. · PubMed · 2
El efecto visual y la necesidad de la determinación de un método de blanqueamiento superficial de la nuez de macadamia
2017 · María José Jijón, Teresa Guerrero Villegas, et al. · Enfoque UTE · 1
PDF
Accidentes en la infancia: a propósito de 14301 casos atendidos durante 1 año
1991 · Jorge Elías, César Joaquín García Vera, et al. · Anales de Pediatría · 1
91O Phase I results PI3Ka inhibitor TOS-358
2026 · V. Abramson, B. Doger de Spéville, et al. · ESMO Open
PDF
Complete genome sequences of seven Ralstonia solanacearum phylotype IIB-4C/IIB-4E strains isolated from plantain trees in Ecuador
2026 · Rommel Guevara, Teresa Guerrero, et al. · Microbiology Resource Announcements
154P Epigenetic innovation in oncology: A clinical snapshot of chromatin remodeler agents in solid tumors from phase I trials
2025 · M. Avedillo Ruidiaz, M. Pedregal Trujillo, et al. · Annals of Oncology
1585TiP A phase I study of ATTR-01, a novel oncolytic adenovirus targeting αvβ6 integrin, which expresses the anti-PD-L1 antibody payload in tumour following intravenous delivery in patients with selected epithelial tumours
2025 · A. Samson, E. Calvo, et al. · Annals of Oncology
619TiP PIKALO-1: A phase I/II trial of LY4064809 (STX-478), a pan-mutant-selective PI3Kα inhibitor in PIK3CA-mutant (PIK3CAm) advanced breast cancer (ABC) and other solid tumors (Trial in Progress)
2025 · A. Giordano, A.J. Montero, et al. · Annals of Oncology
LBA26 A phase I/II trial of LY4064809 (STX-478), a pan-mutant-selective PI3Kα inhibitor: Updated PIKALO-1 results
2025 · D. Juric, A. Giordano, et al. · Annals of Oncology
PDF
36P Unveiling the toxicity landscape: Insights from 112 patients treated with chromatin remodeler agents in a phase I unit
2025 · M. Pedregal Trujillo, M. Avedillo Ruidiaz, et al. · ESMO Open
PDF
Bacteriophages as an alternative to the use of antibiotics in poultry breeding
2019 · Teresa Guerrero, Sonia Zapata · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET)
PDF
Una imagen vale más que mil anamnesis
2018 · V. Fernández Ventureira, Juan Hidalgo Sanz, et al. · Dialnet (Universidad de la Rioja)
Dermatitis granulomatosa perioral de la infancia
2017 · María García Ventura, Teresa Cenarro Guerrero, et al. · Boletín de la Sociedad de Pediatría de Aragón, La Rioja y Soria
No puedo jugar con agua
2015 · Teresa Cenarro Guerrero, César Joaquín García Vera, et al. · Boletín de la Sociedad de Pediatría de Aragón, La Rioja y Soria
Works count: 34
Citation count: 104
H-index: 5
I10-index: 4
Year
Topic
Type